Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Dermand is active.

Publication


Featured researches published by John Dermand.


American Journal on Addictions | 2006

Cannabis Withdrawal Among Non-Treatment-Seeking Adult Cannabis Users

Marc L. Copersino; Susan J. Boyd; Donald P. Tashkin; Marilyn A. Huestis; Stephen J. Heishman; John Dermand; Michael S. Simmons; David A. Gorelick

This study investigates the clinical significance of a cannabis withdrawal syndrome in 104 adult, non-treatment-seeking, primarily cannabis users who reported at least one serious attempt to stop using cannabis. Retrospective self-report data were obtained on eighteen potential cannabis withdrawal symptoms derived from the literature, including co-occurrence, time course, and any actions taken to relieve the symptom. Study findings provide evidence for the clinical significance of a cannabis withdrawal syndrome, based on the high prevalence and co-occurrence of multiple symptoms that follow a consistent time course and that prompt action by the subjects to obtain relief, including serving as negative reinforcement for cannabis use.


American Journal on Addictions | 2006

Quitting Among Non-Treatment-Seeking Marijuana Users: Reasons and Changes in Other Substance Use

Marc L. Copersino; Susan J. Boyd; Donald P. Tashkin; Marilyn A. Huestis; Stephen J. Heishman; John Dermand; Michael S. Simmons; David A. Gorelick

This study examines the self-reported reasons for quitting marijuana use, changes in other substance use during the quit attempt, and reasons for the resumption of use in 104 non-treatment-seeking adult marijuana smokers. Reasons for quitting were shown to be primarily motivated by concerns about the negative impact of marijuana on health and on self- and social image. The spontaneous quitting of marijuana use is often associated with an increase in the use of legal substances such as alcohol, tobacco, and sleeping aids, but not with the initiation of new substance use. These findings suggest areas for further research on spontaneous recovery from marijuana use.


American Journal of Respiratory and Critical Care Medicine | 2015

Topographic Diversity of the Respiratory Tract Mycobiome and Alteration in HIV and Lung Disease

Lijia Cui; Lorrie Lucht; Laura Tipton; Matthew B. Rogers; Adam Fitch; Cathy Kessinger; Danielle Camp; Lawrence A. Kingsley; Nicolas Leo; Ruth M. Greenblatt; Serena Fong; Stephen Stone; John Dermand; Eric C. Kleerup; Laurence Huang; Alison Morris; Elodie Ghedin

RATIONALE Microbiome studies typically focus on bacteria, but fungal species are common in many body sites and can have profound effects on the host. Wide gaps exist in the understanding of the fungal microbiome (mycobiome) and its relationship to lung disease. OBJECTIVES To characterize the mycobiome at different respiratory tract levels in persons with and without HIV infection and in HIV-infected individuals with chronic obstructive pulmonary disease (COPD). METHODS Oral washes (OW), induced sputa (IS), and bronchoalveolar lavages (BAL) were collected from 56 participants. We performed 18S and internal transcribed spacer sequencing and used the neutral model to identify fungal species that are likely residents of the lung. We used ubiquity-ubiquity plots, random forest, logistic regression, and metastats to compare fungal communities by HIV status and presence of COPD. MEASUREMENTS AND MAIN RESULTS Mycobiomes of OW, IS, and BAL shared common organisms, but each also had distinct members. Candida was dominant in OW and IS, but BAL had 39 fungal species that were disproportionately more abundant than in the OW. Fungal communities in BAL differed significantly by HIV status and by COPD, with Pneumocystis jirovecii significantly overrepresented in both groups. Other fungal species were also identified as differing in HIV and COPD. CONCLUSIONS This study systematically examined the respiratory tract mycobiome in a relatively large group. By identifying Pneumocystis and other fungal species as overrepresented in the lung in HIV and in COPD, it is the first to determine alterations in fungal communities associated with lung dysfunction and/or HIV, highlighting the clinical relevance of these findings. Clinical trial registered with www.clinicaltrials.gov (NCT00870857).


American Journal of Drug and Alcohol Abuse | 2010

Sociodemographic Characteristics of Cannabis Smokers and the Experience of Cannabis Withdrawal

Marc L. Copersino; Susan J. Boyd; Donald P. Tashkin; Marilyn A. Huestis; Stephen J. Heishman; John Dermand; Michael S. Simmons; David A. Gorelick

Background: Cannabis withdrawal can be a negative reinforcer for relapse, but little is known about its association with demographic characteristics. Objectives: Evaluate the association of demographic characteristics with the experience of cannabis withdrawal. Methods: Retrospective self-report of a “serious” cannabis quit attempt without formal treatment in a convenience sample of 104 non-treatment-seeking, adult cannabis smokers (mean age 35 years, 52% white, 78% male) with no other current substance use disorder (except tobacco) or chronic health problems. Reasons for quitting, coping strategies to help quit, and 18 specific withdrawal symptoms were assessed by questionaire. Results: Among withdrawal symptoms, only anxiety, increased sex drive, and craving showed significant associations with age, race, or sex. Women were more likely than men to report a physical withdrawal symptom (OR = 3.2, 95% CI = .99–10.4, p = .05), especially upset stomach. There were few significant demographic associations with coping strategies or reasons for quitting. Conclusions and Scientific Significance: This small study suggests that there are few robust associations between demographic characteristics and cannabis withdrawal. Future studies with larger samples are needed. Attention to physical withdrawal symptoms in women may help promote abstinence.


Journal of AIDS and Clinical Research | 2014

Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti- Retroviral Therapy

Joseph Simonetti; Matthew R. Gingo; Lawrence A. Kingsley; Cathy Kessinger; Lorrie Lucht; G.K. Balasubramani; Joseph K. Leader; Laurence Huang; Ruth M. Greenblatt; John Dermand; Eric C. Kleerup; Alison Morris

BACKGROUND Individuals with HIV infection commonly have pulmonary function abnormalities, including airflow obstruction and diffusion impairment, which may be more prevalent among recreational drug users. To date, the relationship between drug use and pulmonary function abnormalities among those with HIV remains unclear. OBJECTIVE To determine associations between recreational drug use and airflow obstruction, diffusion impairment, and radiographic emphysema in men and women with HIV. METHODS Cross-sectional analysis of pulmonary function and self-reported recreational drug use data from a cohort of 121 men and 63 women with HIV. Primary outcomes were the presence (yes/no) of: 1) airflow obstruction, (pre- or post-bronchodilator forced expiratory volume in 1 second/forced vital capacity<0.70); 2) moderate diffusion impairment (diffusing capacity for carbon monoxide <60% predicted); and 3) radiographic emphysema (>1% of lung voxels <-950 Hounsfield units). Exposures of interest were frequency of recreational drug use, recent (since last study visit) drug use, and any lifetime drug use. We used logistic regression to determine associations between recreational drug use and the primary outcomes. RESULTS HIV-infected men and women reported recent recreational drug use at 56.0% and 31.0% of their study visits, respectively, and 48.8% of men and 39.7% of women reported drug use since their last study visit. Drug use was not associated with airway obstruction or radiographic emphysema in men or women. Recent crack cocaine use was independently associated with moderate diffusion impairment in women (odds ratio 17.6; 95% confidence interval 1.3-249.6, p=0.03). CONCLUSIONS In this cross-sectional analysis, we found that recreational drug use was common among HIV-infected men and women and recent crack cocaine use was associated with moderate diffusion impairment in women. Given the increasing prevalence of HIV infection, any relationship between drug use and prevalence or severity of chronic pulmonary diseases could have a significant impact on HIV and chronic disease management.


American Journal of Respiratory and Critical Care Medicine | 2002

A Pilot Study of All-trans-Retinoic Acid for the Treatment of Human Emphysema

Jenny T. Mao; Jonathan G. Goldin; John Dermand; Grace Ibrahim; Mathew S. Brown; Aletha M. Emerick; Michael F. McNitt-Gray; David W. Gjertson; Francine Estrada; Donald P. Tashkin; Michael D. Roth


American Journal of Respiratory and Critical Care Medicine | 1999

Exhaled nitric oxide measurements in a population sample of young adults.

Cheryl M. Salome; Alyson M. Roberts; Nathan J. Brown; John Dermand; Guy B. Marks; Ann J. Woolcock


american thoracic society international conference | 2012

Comparison Of The Respiratory Microbiome In HIV-Infected And HIV-Uninfected Individuals

Alex W. Ireland; Elodie Ghedin; Mihai Pop; Kazima Saira; Lorrie Lucht; Joseph N. Paulson; Maria E. Hillenbrand; Michelle Busch; Cathy Kessinger; Tammi Lawther; Adam Fitch; Jay V. DePasse; Serena Fong; John Dermand; Lawerence Kingsley; Eric C. Kleerup; Laurence Huang; Alison Morris


american thoracic society international conference | 2012

Pulmonary Function In HIV-Infected Drug Users In The Era Of Anti-Retroviral Therapy

Joseph Simonetti; Matthew R. Gingo; Cathy Kessinger; Lorrie Lucht; Laurence Huang; Heneliaka Jones; Nancy A. Hessol; Claudia Ponath; Ruth M. Greenblatt; John Dermand; Roger Detels; Eric C. Kleerup; Alison Morris


Alcoologie et Addictologie | 2004

Stratégies de sevrage utilisées par les fumeurs de cannabis non demandeurs d'un traitement.

Susan J. Boyd; Donald P. Tashkin; Marilyn A. Huestis; Stephen J. Heishman; John Dermand; Michael S. Simmons; David A. Gorelick

Collaboration


Dive into the John Dermand's collaboration.

Top Co-Authors

Avatar

Alison Morris

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laurence Huang

University of California

View shared research outputs
Top Co-Authors

Avatar

Lorrie Lucht

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marilyn A. Huestis

National Institute on Drug Abuse

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge